List of Apogenix patents

Patents where

Current Assignee

Name

‌

Apogenix

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8383774 Collectin fusion proteins comprising TNF or trail	Patent 8383774 was granted and assigned to Apogenix on February, 2013 by the United States Patent and Trademark Office.		‌ Apogenix	United States Patent and Trademark Office	8383774	February 26, 2013
‌ US Patent 9340599 Single chain CD40L fusion polypeptides	Patent 9340599 was granted and assigned to Apogenix on May, 2016 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9340599	May 17, 2016
‌ US Patent 8450460 Single-chain TNFSF fusion polypeptides	Patent 8450460 was granted and assigned to Apogenix on May, 2013 by the United States Patent and Trademark Office.		‌ Apogenix	United States Patent and Trademark Office	8450460	May 28, 2013
‌ US Patent 9359420 Single chain trail fusion polypeptides and encoding nucleic acids	Patent 9359420 was granted and assigned to Apogenix on June, 2016 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9359420	June 7, 2016
‌ US Patent 8921519 Single chain fusion polypeptides comprising soluble light cytokine domains	Patent 8921519 was granted and assigned to Apogenix on December, 2014 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	8921519	December 30, 2014
‌ US Patent 10428154 Monoclonal anti-CD95L antibody	Patent 10428154 was granted and assigned to Apogenix on October, 2019 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	10428154	October 1, 2019
‌ US Patent 11014991 Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody	Patent 11014991 was granted and assigned to Apogenix on May, 2021 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	11014991	May 25, 2021
‌ US Patent 9527897 CD40L collectin fusion proteins and encoding nucleic acid molecules	Patent 9527897 was granted and assigned to Apogenix on December, 2016 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9527897	December 27, 2016
‌ US Patent 9469681 Fusion proteins forming trimers	Patent 9469681 was granted and assigned to Apogenix on October, 2016 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9469681	October 18, 2016
‌ US Patent 9315570 Composition comprising a mixture of CD95-Fc isoforms and methods of producing same	Patent 9315570 was granted and assigned to Apogenix on April, 2016 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9315570	April 19, 2016
‌ US Patent 9657083 Composition comprising a mixture of CD95-Fc isoforms	Patent 9657083 was granted and assigned to Apogenix on May, 2017 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9657083	May 23, 2017
‌ US Patent 8664366 Fusion proteins forming trimers	Patent 8664366 was granted and assigned to Apogenix on March, 2014 by the United States Patent and Trademark Office.		‌ Apogenix	United States Patent and Trademark Office	8664366	March 4, 2014
‌ US Patent 9540431 Inhibitors of the CD95 signaling pathway for treatment of MDS	Patent 9540431 was granted and assigned to Apogenix on January, 2017 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9540431	January 10, 2017
‌ US Patent 10266600 Diagnostic anti-CD95L antibody	Patent 10266600 was granted and assigned to Apogenix on April, 2019 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	10266600	April 23, 2019
‌ US Patent 11149075 Single-chain glucocorticoid-induced tumor necrosis factor receptor (GITR) receptor agonist proteins	Patent 11149075 was granted and assigned to Apogenix on October, 2021 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	11149075	October 19, 2021
‌ US Patent 9908928 Artificial signal peptide	Patent 9908928 was granted and assigned to Apogenix on March, 2018 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9908928	March 6, 2018
‌ US Patent 10118953 Glucocorticoid-induced tumor necrosis factor receptor ligand (GITRL) single-chain fusion polypeptides	Patent 10118953 was granted and assigned to Apogenix on November, 2018 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	10118953	November 6, 2018
‌ US Patent 11214605 Light single-chain fusion polypeptides, encoding nucleic acid molecules and host cells	Patent 11214605 was granted and assigned to Apogenix on January, 2022 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	11214605	January 4, 2022
‌ US Patent 10519217 CD27L collectin fusion proteins and encoding nucleic acids	Patent 10519217 was granted and assigned to Apogenix on December, 2019 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	10519217	December 31, 2019
‌ US Patent 8147843 CD95L or trail fusion proteins	Patent 8147843 was granted and assigned to Apogenix on April, 2012 by the United States Patent and Trademark Office.		‌ Apogenix	United States Patent and Trademark Office	8147843	April 3, 2012
‌ US Patent 8907063 TNF superfamily collectin fusion proteins and encoding nucleic acids	Patent 8907063 was granted and assigned to Apogenix on December, 2014 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	8907063	December 9, 2014
‌ US Patent 9212211 Trail collectin fusion proteins	Patent 9212211 was granted and assigned to Apogenix on December, 2015 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9212211	December 15, 2015
‌ US Patent 9434783 Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof	Patent 9434783 was granted and assigned to Apogenix on September, 2016 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	9434783	September 6, 2016
‌ US Patent 10519208 CD40L single-chain fusion polypeptides and encoding nucleic acids	Patent 10519208 was granted and assigned to Apogenix on December, 2019 by the United States Patent and Trademark Office.	‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	10519208	December 31, 2019
‌ US Patent 10640543 CD27 ligand (CD27L) single-chain fusion polypeptides		‌ Apogenix	‌ Apogenix	United States Patent and Trademark Office	10640543	May 5, 2020

Results per page:

36 results

0 selected

36 results

0 selected